Chloe Slichter

Director - Discovery Biology Kite Pharma Inc

Seminars

Thursday 3rd December 2026
Exploring CAR-T Cell Combination Strategies & Novel Targeting Approaches in Autoimmunity
2:00 pm
  • Evaluating combination approaches integrating CAR-T cells with monoclonal antibodies to enhance response depth and durability in autoimmune indications
  • Investigating emerging B-cell and T-cell targets to expand treatment impact and improve precision beyond broad depletion strategies
  • Addressing translational challenges including defining immune reset and developing meaningful biomarkers
Chloe Slichter